(Reuters) -An Australian court has moved to prevent U.S. drugmaker Cosette Pharmaceuticals from abandoning its A$672 million ($437.6 million) acquisition of Mayne Pharma, the ASX-listed company said on Thursday.
Cosette has been trying to terminate its offer, after saying in May that it was reviewing the deal because of a “material adverse change” in Mayne’s performance.
($1 = 1.5356 Australian dollars)
(Reporting by Rishav Chatterjee in Bengaluru; Editing by Shailesh Kuber)
Brought to you by www.srnnews.com